Pulmonary Drugs Market is Expected to Witness Massive Growth as AstraZeneca enters into Partnership with Propeller Health to add Smart Features to its Symbicort Inhaler for the Treatment of COPD

     


Chronic obstructive pulmonary disease (COPD) or also known as chronic obstructive respiratory disease is a progressive condition wherein the airways become swollen, inflamed, and clogged due to the buildup of mucus. This mucus becomes the first line of defense against any irritant which leads to difficulty in breathing, coughing, chest pain, wheezing, and shortness of breath. With time, this mucous thickens and makes it difficult for the air to pass through.

Increasing incidence of respiratory diseases is expected to drive growth of the global pulmonary drugs market. According to the Centers for Disease Control Prevention (CDC), over 25 million U.S. citizens have asthma. According to the same source, in 2017, around 1 in children had asthma. Moreover, according to the World Health Organization (WHO), in 2016, around 251 million cases of chronic pulmonary obstructive disease (COPD) were reported globally. Such a massive increase in respiratory diseases has increased the demand for pulmonary drugs worldwide. Pulmonary drug delivery offers numerous advantages due to the large internal surface area of the lung. Hence, such factors are expected to drive growth of the global pulmonary drugs market. Furthermore, growing emphasis on the development of smart or digital inhalers is expected to propel the global pulmonary drugs market growth in the near future.

Concerns regarding stringent regulatory policies and side-effects associated with some drugs are expected to restrain growth of the global pulmonary drugs market. However, emergence of online marketing channels and rising demand from emerging economies can provide lucrative growth opportunities in the global pulmonary drugs market. Among regions, North America is expected to witness significant growth in the global pulmonary drugs market. This is owing to increasing prevalence of respiratory diseases in the region. According to the Cystic Fibrosis Foundation (CFF), in the U.S., over 1,000 new cases of cystic fibrosis are diagnosed each year. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to improving healthcare infrastructure and growing patient awareness in the region.

Key competitors involved in the global pulmonary drugs market are AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sumitomo Dainippon Pharma Co., Ltd., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, Pfizer Inc., Grifols, S.A., and Merck & Co., Inc.

For instance, in May 2020, AstraZeneca partnered with Propeller Health to add smart features to its Symbicort inhaler for the treatment of asthma and chronic obstructive pulmonary diseases (COPD). 


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers around th
Read more

Around 80% of the Ammonia Produced By Industry Is Used In Agriculture as Fertilizer

Image
  Ammonia is a compound of hydrogen and nitrogen with the formula NH 3 . It is a colorless gas, highly soluble in water, with a distinct characteristic of a pungent smell. It is widely used in plastics, fiber, mining, pulp and paper, pharmaceutical, chemical, and agriculture industries. Moreover, it is necessary for several important biological functions, such as protein synthesis, nucleic acid production, and the breaking down of DNA. The effects of ammonia on humans vary depending on the level of exposure and how long the person has been exposed. Ammonia gas can irritate the respiratory tract, eyes, nose, and throat. Furthermore, exposed individuals may experience headaches, nausea, diarrhea, vomiting, and stomach cramps. The severity of health effects depends on the route of exposure, the dose, and the duration of exposure. Long-term exposure can result in blindness, lung damage, or death. Ammonia is also highly toxic to pets, causing potentially serious damage to the skin, eyes,
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 canc
Read more